RIRiyan Alifbi Putera Irsal

Riyan Alifbi Putera Irsal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Riyan Alifbi Putera Irsal has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Unveiling the Antitumor Potential of Eugenia calycina Fruit: In silico Exploration of NUDT Enzyme and Estrogen Receptor Alpha Inhibition

    by Fernanda Chairunisa, Tiyara Fany Mansyah, Dzikri Anfasa Firdaus, Maheswari Alfira Dwicesaria, Gusnia Meilin Gholam, Ayu Tri Nursyarah, Syahidatul Helma, Riyan Alifbi Putera Irsal

    Estrogen receptor alpha (ERα) and NUDT5 overexpression are hallmarks of aggressive breast cancer, associated with poor prognosis and therapeutic resistance. This study investigates Eugenia calycina, a plant rich in bioactive compounds, for its potential as an anti-breast cancer agent. We focus on its effects on ERα and NUDT5, an enzyme involved in cancer progression. This study combines molecular docking, DFT, and MD simulations to evaluate Eugenia calycina’s phytochemicals for targeting ERα and NUDT5. The results indicate that PDB2 exhibits superior binding stability compared to reference compounds, as evidenced by lower RMSDbackbone and RMSF values in molecular dynamics simulations. Furthermore, MM-PBSA calculations revealed significantly more negative binding free energies for PDB2 with both NUDT5 and ERα, suggesting stronger interactions. Quantum chemical calculations provided insights into the electronic properties of the compounds, revealing PDB2's potential for favourable interactions due to its smaller HOMO-LUMO energy gap. DFT analysis assessed stability, showing comparable values for the investigated compounds. Molecular docking reveals promising binding affinities of phytochemicals, particularly procyanidin dimer B2. Computational analysis and MD simulation revealed superior stability to reference compounds. While initial predictions indicate a favourable safety profile, further experimental validation is crucial to confirm these findings and their therapeutic potential.

  • Open Access

    Computational Evaluation of Sea Buckthorn Phytochemicals as CDPK3 and CDPK4 Inhibitors against Plasmodium falciparum

    by Wirdatun Nafisah, Gusnia Meilin Gholam, Riyan Alifbi Putera Irsal, Maheswari Alfira Dwicesaria, Elma Sakinatus Sajidah, Fatima Shahid, Fachrur Rizal Mahendra, David Herawan, Rahmah Muthmainnah Azam

    Malaria remains a primary global health concern, and targeting proteins from the calcium-dependent protein kinase (CDPK) family of Plasmodium falciparum represents a novel and promising therapeutic strategy. In this study, we investigated the molecular interactions between sea buckthorn-derived compounds and P. falciparum CDPK3 and CDPK4 to address the unexplored antimalarial potential of this traditionally used medicinal plant. The active sites of each CDPK protein were predicted to facilitate docking analysis. In silico assessments of absorption, distribution, metabolism, and excretion (ADME), along with PASS, were used to evaluate drug-likeness properties and antiprotozoal potential. Density functional theory (DFT) calculations were performed to predict the electronic reactivity of potential inhibitors, and molecular dynamics (MD) simulations were used to evaluate complex stability. The results showed that the active sites of CDPK3 and CDPK4 were successfully identified, with 39 amino acid residues for CDPK3 and 105 for CDPK4. Molecular docking analyses demonstrated favorable binding affinities, ranging from 4.026 to 8.917 kcal/mol for the CDPK3–ligand complexes and from 5.072 to 11.09 kcal/mol for the CDPK4–ligand complexes. Among all evaluated compounds, oleanolic acid and ursolic acid exhibited the highest predicted drug-likeness and strong antiprotozoal activity, as supported by PASS predictions. DFT calculations further reinforced their inhibitory potential, with both compounds showing an extremely small energy gap difference of −0.0002 eV. In addition, MD simulations using normal mode analysis (NMA) showed that the candidate inhibitors formed stable complexes with both CDPK3 and CDPK4.

  • Open Access

    Computational exploration of palmitoyl-protein thioesterase 1 inhibition by Juniperus phoenicea L. for anti-dementia treatment

    by Riyan A. Putera Irsal, Gusnia Meilin Gholam, Maheswari Alfira Dwicesaria, Tiyara F. Mansyah, Fernanda Chairunisa


  • Open Access

    Exploring the potential of Scabiosa columbaria in Alzheimer's disease treatment: An in silico approach

    by Riyan A.P. Irsal, Gusnia M. Gholam, Maheswari A. Dwicesaria, Tiyara F. Mansyah, Fernanda Chairunisa


  • Computational exploration of compounds in Xylocarpus granatum as a potential inhibitor of Plasmodium berghei using docking, molecular dynamics, and DFT studies

    by Gusnia Meilin Gholam, Fachrur Rizal Mahendra, Riyan Alifbi Putera Irsal, Maheswari Alfira Dwicesaria, Mokhamat Ariefin, Mikael Kristiadi, Andita Fitri Mutiara Rizki, Wihda Aisarul Azmi, I Made Artika, Josephine Elizabeth Siregar


  • Open Access

    Molecular Docking and Dynamics of Xylocarpus granatum as A Potential Parkinson’s Drug Targeting Multiple Enzymes

    by Riyan Alifbi Putera Irsal, Gusnia Meilin Gholam, Dzikri Anfasa Firdaus, Novian Liwanda, Fernanda Chairunisa

    Parkinson's disease is a global health challenge affecting over 10 million individuals worldwide, leading to increased disability-adjusted life years (DALYs) and a rise in mortality rates. This study explores the potential anti-Parkinson's properties of Xylocarpus granatum, focusing on its interaction with key enzymes associated with the disease: catechol-O-methyltransferase (COMT), adenosine A2A receptor (A2AR), and monoamine oxidase-B (MAO-B). Using molecular docking and molecular dynamics approaches with YASARA Structure, the ethanol extract of X. granatum was investigated for its mechanism of action. Among 30 compounds, five demonstrated promising binding affinities. Structural flexibility analysis revealed minimal fluctuations in active-site residues, highlighting the stability of key complexes involving kaempferol, epicatechin, epigallocatechin, and native ligands. Molecular Mechanics Poisson–Boltzmann Surface Area (MM-PBSA) simulations provided insights into the binding energy of these complexes. Notably, kaempferol exhibited higher binding energy than the natural ligand, suggesting superior binding affinity. Analysis of the average radius of gyration (Rg) showcased control drug-MAO-B exhibited higher Rg values, indicating a more flexible protein conformation. Confirming mode stability with root mean square deviation (RMSD) analysis shows overall stability, except in the A2AR-bound complex. The study's collective findings underscore the structural stabilization of ligand-protein complexes, contributing valuable insights into the potential anti-Parkinson's properties of X. granatum. These discoveries hold promise for developing more effective therapies for Parkinson's disease and significantly contribute to the neurology field.


  • Open Access

    In Silico Study of Combined Docking and Molecular Dynamics Simulation for Hops (Humulus lupulus) Active Compounds in Inhibiting Duffy-Binding Protein (DBP) as Anti-Plasmodium vivax (P. vivax)

    by Gusnia Meilin Gholam, Riyan Alifbi Putera Irsal, Maheswari Alfira Dwicesaria, Muhammad Marsha Azzami Hasibuan

    Malaria is one of the infectious illnesses causing a public health burden worldwide. Plasmodium vivax (P. vivax) is the most prevalent malaria parasite in Asia and Asia Pacific. P. vivax is resistant to sulfadoxine–pyrimethamine (SP) and mefloquine. This resistance makes it extremely difficult to control and eradicate due to its ability to survive in the liver and reactivate if the person infected has a weakened immune system. Thus, this study aims to inhibit P. vivax via targeting Duffy-binding protein (DBP) with active compounds from Hops (Humulus lupulus). The inhibition of DBP is essential to reduce malaria invasion of human red blood cells. We performed a quality assessment and prediction of the active site of DBP to determine the effectiveness and prediction of ligands in inhibiting DBP. Furthermore, the mechanism and structural stability of active compounds against DBP were evaluated using a combination of molecular docking and molecular dynamics simulation and a density-functional theory (DFT) study. The results showed that rutin had the highest binding of 8.852 kcal/mol. However, after the molecular dynamics simulation was run for 50 ns, the ligand 6-prenylnaringenin via MM-PBSA calculation showed the most positive value of 106.760 kJ/mol. In addition, 6-prenylnaringenin is the most stable ligand via the analysis of root-mean-square deviation backbone (RMSDBb), root-mean-square deviation c-alpha (RMSDCa), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), radius of gyration (Rg), and the hydrogen bond formation. We conclude that 6-prenylnaringenin has a tight and stable bond with the targeted DBP protein. Finally, we propose the use of 6-prenylnaringenin as a potential antimalarial compound via in silico studies.